Inventor
Atsushi Endo
Inventor
Andover, MA, US
Overview
Patents· 27 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds24%
Y02PClimate change mitigation technologies in the production or processing of goods19%
A61KPreparations for medical, dental or toiletry purposes16%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium11%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations10%
C07BGeneral methods of organic chemistry9%
C07HSugars4%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
PatentTitleYear
11,130,758Tetrahydropyrazolopyrimidine compounds202110,981,929Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof202110,836,784Substituted phosphorodiamidate morpholino oligomers202010,745,387Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(piridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-1-carboxylate and methods of use thereof202010,717,743Intermediates and methods for the synthesis of halichondrin B analogs202010,640,500Tetrahydropyrazolopyrimidine compounds202010,618,930Compounds for the treatment of cancer202010,494,388Compounds useful in the synthesis of halichondrin B analogs201910,457,698Chiral reagents for preparation of substituted phosphorodiamidate morpholino oligomers201910,246,480Compounds for the treatment of cancer201910,214,539Intermediates and methods for the synthesis of halichondrin B analogs2019RE047193Selectively substituted quinoline compounds201910,087,174Selectively substituted quinoline compounds20189,856,276'Compounds useful in the synthesis of halichondrin B analogs'20189,850,242Tetrahydropyrazolopyrimidine compounds20179,802,953'Intermediates and methods for the synthesis of halichondrin B analogs'20179,663,486'Selectively substituted quinoline compounds'20179,604,993'Intermediates and methods for the synthesis of halichondrin B analogs'20179,446,046'Tetrahydropyrazolopyrimidine compounds'20169,428,495'Selectively substituted quinoline compounds'20169,382,262'Compounds useful in the synthesis of halichondrin B analogs'20169,126,999'Tetrahydropyrazolopyrimidine compounds'20158,987,479'Intermediates and methods for the synthesis of halichondrin B analogs'20158,927,597'Compounds useful in the synthesis of halichondrin B analogs'20158,350,067'Compounds useful in the synthesis of halichondrin B analogs'20138,203,010'Compounds useful in the synthesis of halichondrin B analogs'20128,093,410'Intermediates and methods for the synthesis of halichondrin B analogs'2012Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2012–2021Patents assigned to EISAI R&D MAN CO LTD (26)· patent assignee history
2012–2015Patents assigned to ENDO ATSUSHI (6)· patent assignee history
2012–2015Patents assigned to FANG FRANCIS G (4)· patent assignee history
2012–2015Patents assigned to CHASE CHARLES E (3)· patent assignee history
2012–2015Patents assigned to CHASE CHARLES (2)· patent assignee history
2012–2020Based in Boston, MA, US· patent location history
2015–2021Based in Andover, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| EISAI R&D MAN CO LTD | 26 | 2012–2021 |
| ENDO ATSUSHIself | 6 | 2012–2015 |
| FANG FRANCIS G | 4 | 2012–2015 |
| CHASE CHARLES E | 3 | 2012–2015 |
| CHASE CHARLES | 2 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Andover, Massachusetts, US | 15 | 2015–2021 |
| Boston, Massachusetts, US | 12 | 2012–2020 |